Erika Kajdácsi, MSc, Péter K

Slides:



Advertisements
Similar presentations
Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
Advertisements

Hereditary angioedema: A decade of human C1-inhibitor concentrate therapy  Henriette Farkas, MD, PhD, DSc, László Jakab, MD, György Temesszentandrási,
Peter Vadas, MD, PhD, Boris Perelman, PhD, Gary Liss, MD, MS 
Serum granzymes and CD30 are increased in children's milk protein sensitive enteropathy and celiac disease  Merja T. Augustin, MD, Jorma Kokkonen, MD,
Treatment of attacks with plasma-derived C1-inhibitor concentrate in pediatric hereditary angioedema patients  Henriette Farkas, MD, PhD, DSc, Dorottya.
Serum granzymes and CD30 are increased in children's milk protein sensitive enteropathy and celiac disease  Merja T. Augustin, MD, Jorma Kokkonen, MD,
Chlamydophila (Chlamydia) pneumoniae serology and asthma in adults: A longitudinal analysis  Rafael Pasternack, MD, PhD, Heini Huhtala, MSc, Jussi Karjalainen,
Jay A. Lieberman, MD, Faith R. Huang, MD, Hugh A
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Stephen J. Fowler, MD, Gaël Tavernier, PhD, Robert Niven, MD 
Antti E. Seppo, PhD, Chloe A. Autran, MSc, Lars Bode, PhD, Kirsi M
Long-term immune reconstitution after matched unrelated hematopoietic stem cell transplantation for immunodeficiency  Vy Hong-Diep Kim, MD, Brenda Reid,
Dorothy M. Ryan, MD, Stephen J. Fowler, MD, Robert M. Niven, MD 
Incident asthma and Mycoplasma pneumoniae: A nationwide cohort study
Is 9 more than 2 also in allergic airway inflammation?
Desensitization to Chemotherapeutic Agents
Activation of the ficolin-lectin pathway during attacks of hereditary angioedema  Dorottya Csuka, PhD, Lea Munthe-Fog, PhD, Estrid Hein, MSc, Zsuzsanna.
Treatment of attacks with plasma-derived C1-inhibitor concentrate in pediatric hereditary angioedema patients  Henriette Farkas, MD, PhD, DSc, Dorottya.
Erika Kajdácsi, MSc, Péter K
Short-term prophylaxis in a patient with acquired C1-INH deficiency
Hereditary angioedema: Molecular and clinical differences among European populations  Matthaios Speletas, MD, PhD, Agnes Szilagyi, PhD, Fotis Psarros,
Reduced serologic response to mumps, measles, and rubella vaccination in patients treated with intravenous immunoglobulin for Kawasaki disease  Carline.
Hereditary angioedema: Safety of long-term stanozolol therapy
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J
Cleaved kininogen as a biomarker for bradykinin release in hereditary angioedema  Zonne L.M. Hofman, MSc, Steven de Maat, PhD, Chiara Suffritti, PhD, Andrea.
Antibiotic use in infancy and symptoms of asthma, rhinoconjunctivitis, and eczema in children 6 and 7 years old: International Study of Asthma and Allergies.
The National Biome Initiative: An allergy perspective
Physician needs in health informatics: Just ask the docs
A focused parameter update: Hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor–associated angioedema 
Peter M. Wolfgram, MD, David B. Allen, MD 
Asthma symptom re-emergence after omalizumab withdrawal correlates well with increasing IgE and decreasing pharmacokinetic concentrations  Raymond G.
William J. Calhoun, MD, Tmirah Haselkorn, PhD, Dave P
Jewlya Lynn, PhD, Sophie Oppenheimer, MS, MPH, Lorena Zimmer, MA 
Serum tryptase levels in atopic and nonatopic children
Respiratory sensitization of a worker to the warehouse beetle Trogoderma variabile: An index case report  Jonathan A. Bernstein, MD, Marjorie S. Morgan,
Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation  Leif Bjermer, MD  Journal of Allergy.
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management  Scott H. Sicherer, MD, Hugh A. Sampson, MD  Journal.
Biosimilars and drug development in allergic and immunologic diseases
Hereditary angioedema: A decade of human C1-inhibitor concentrate therapy  Henriette Farkas, MD, PhD, DSc, László Jakab, MD, György Temesszentandrási,
Reply Journal of Allergy and Clinical Immunology
Airborne cat allergen reduction in classrooms that use special school clothing or ban pet ownership  Anne-Sophie Karlsson, MSc, Berith Andersson, SRN,
Daphne Koinis-Mitchell, PhD, Timothy Craig, DO, Cynthia A
Peter Vadas, MD, PhD, Boris Perelman, PhD, Gary Liss, MD, MS 
Priscilla Auyeung, PhD, Diana Mittag, PhD, Philip D
What is an “eosinophilic phenotype” of asthma?
Opsonic function of bronchoalveolar lavage IgG after pneumococcal vaccination in HIV- infected and uninfected adults  Jerry C.H. Tam, Nicola L. Grant,
H. William Kelly, PharmD  Journal of Allergy and Clinical Immunology 
Autophagy: Nobel Prize 2016 and allergy and asthma research
News & Notes Journal of Allergy and Clinical Immunology
Higher incidence of pediatric anaphylaxis in northern areas of the United States  William J. Sheehan, MD, Dionne Graham, PhD, Lin Ma, MS, Sachin Baxi,
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
Advances in the approach to the patient with food allergy
Sputum inflammatory cells from patients with allergic rhinitis and asthma have decreased inflammasome gene expression  Willie June Brickey, PhD, Neil.
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Martin Brasholt, MD, Florent Baty, PhD, Hans Bisgaard, MD, DMSci 
Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency  Marcel Levi, MD,
Reply Journal of Allergy and Clinical Immunology
Thunderstorm-related asthma attacks
Measles and immunomodulation
Metallopeptidase activities in hereditary angioedema: Effect of androgen prophylaxis on plasma aminopeptidase P  Christian Drouet, PhD, Anik Désormeaux,
Macrolide antibiotics and asthma treatment
Statistical issues in clinical trials that involve the double-blind, placebo-controlled food challenge  Vernon M. Chinchilli, PhD, Laura Fisher, MD, Timothy.
Asthma: The past, future, environment, and costs
Pru p 3 as a marker for symptom severity for patients with peach allergy in a birch pollen environment  Sonja Gaier, MSc, Christina Oberhuber, PhD, Wolfgang.
Environmental factors and eosinophilic esophagitis
Effect of codeine on objective measurement of cough in chronic obstructive pulmonary disease  Jaclyn Smith, MD, PhD, Emily Owen, MPhil, John Earis, MD,
Endogenous bradykinin and B1-B5 during angiotensin-converting enzyme inhibitor– associated angioedema  Scott A. Hubers, MD, Kevin Kohm, MS, Shouzuo Wei,
Natural history of cow’s milk allergy
Susan L. Janson, DNSc, Kelly Wong McGrath, BA, Jack K
Primary prevention of asthma and allergy
Presentation transcript:

Endothelial cell activation during edematous attacks of hereditary angioedema types I and II  Erika Kajdácsi, MSc, Péter K. Jani, MSc, Dorottya Csuka, PhD, Lilian Ágnes Varga, PhD, Zoltán Prohászka, MD, DSc, Henriette Farkas, MD, DSc, László Cervenak, PhD  Journal of Allergy and Clinical Immunology  Volume 133, Issue 6, Pages 1686-1691 (June 2014) DOI: 10.1016/j.jaci.2013.12.1072 Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Endothelial marker levels of patients with HAE between and during attacks. VWF:Ag (A), VWF:CBA (B), sE-selectin (C), and ET-1 (D) were compared. The Wilcoxon matched pairs test (VWF:Ag, VWF:CBA, and sE-selectin) or the parametric paired t test (ET-1) was used for comparisons. P values and the direction of change are indicated (n = 18). Normal ranges are shown in Table I. Journal of Allergy and Clinical Immunology 2014 133, 1686-1691DOI: (10.1016/j.jaci.2013.12.1072) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Comparison of endothelial marker levels in nonsmoking subgroups of patients with HAE (n = 13). Inter-attack and during-attack samples were compared for VWF:Ag (A), VWF:CBA (B), sE-selectin (C), and ET-1 (D). The Wilcoxon matched pairs test (VWF:CBA, sE-selectin, and ET-1) or the parametric paired t test (VWF:Ag) was used for comparison. P values are indicated. Normal ranges are shown in Table I. Journal of Allergy and Clinical Immunology 2014 133, 1686-1691DOI: (10.1016/j.jaci.2013.12.1072) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 3 Comparison of endothelial marker levels in danazol-treated and nontreated subgroups of patients with HAE. Inter-attack (IA) and during-attack (DA) samples were compared for VWF:Ag (A) and VWF:CBA (B). The Wilcoxon matched pairs test was used for comparison in both danazol-treated (n = 7) and non–danazol-treated (n = 9) subgroups. P values are indicated. Normal ranges are shown in Table I. Journal of Allergy and Clinical Immunology 2014 133, 1686-1691DOI: (10.1016/j.jaci.2013.12.1072) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 4 Distribution of EC markers during multiple attacks in the same patients with HAE. VWF:Ag (A), VWF:CBA (B), sE-selectin (C), and ET-1 (D) were assessed in 8 patients with more than 1 during-attack sample. Each during-attack (DA) value was divided by the corresponding inter-attack (IA) value, and these ratios were plotted as open circles. The medians of the ratios are presented as a solid line. The values under the dotted line represent decreased levels, whereas those above the dotted line correspond to increased EC marker levels. Journal of Allergy and Clinical Immunology 2014 133, 1686-1691DOI: (10.1016/j.jaci.2013.12.1072) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions